Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases

T. Nie, L. You, F. Tang, Y. Duan, E. Nepovimova, K. Kuca, Q. Wu, W. Wei

. 2025 ; 23 (5) : 524-546. [pub] -

Jazyk angličtina

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25016434

Grantová podpora
32373073 National Natural Science Foundation of China
2023KF02 Key Laboratory of Traceability for Agricultural Genetically Modified Organisms, Ministry of Agriculture and Rural Affairs
UHHK, 00179906 MH CZ - DRO
22FWWB003 National Social Science Foundation
2216/2023-2024 Excellence project PrF UHK, Czech Republic

BACKGROUND: Age-related neurodegenerative diseases (NDs) pose a formidable challenge to healthcare systems worldwide due to their complex pathogenesis, significant morbidity, and mortality. Scope and Approach: This comprehensive review aims to elucidate the central role of the microbiotagut- brain axis (MGBA) in ND pathogenesis. Specifically, it delves into the perturbations within the gut microbiota and its metabolomic landscape, as well as the structural and functional transformations of the gastrointestinal and blood-brain barrier interfaces in ND patients. Additionally, it provides a comprehensive overview of the recent advancements in medicinal and dietary interventions tailored to modulate the MGBA for ND therapy. CONCLUSION: Accumulating evidence underscores the pivotal role of the gut microbiota in ND pathogenesis through the MGBA. Dysbiosis of the gut microbiota and associated metabolites instigate structural modifications and augmented permeability of both the gastrointestinal barrier and the blood-brain barrier (BBB). These alterations facilitate the transit of microbial molecules from the gut to the brain via neural, endocrine, and immune pathways, potentially contributing to the etiology of NDs. Numerous investigational strategies, encompassing prebiotic and probiotic interventions, pharmaceutical trials, and dietary adaptations, are actively explored to harness the microbiota for ND treatment. This work endeavors to enhance our comprehension of the intricate mechanisms underpinning ND pathogenesis, offering valuable insights for the development of innovative therapeutic modalities targeting these debilitating disorders.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016434
003      
CZ-PrNML
005      
20250731092911.0
007      
ta
008      
250708s2025 ts f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1570159X23666241101093436 $2 doi
035    __
$a (PubMed)39501955
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Nie, Tong $u College of Life Science, Yangtze University, Jingzhou, 434025, China
245    10
$a Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases / $c T. Nie, L. You, F. Tang, Y. Duan, E. Nepovimova, K. Kuca, Q. Wu, W. Wei
520    9_
$a BACKGROUND: Age-related neurodegenerative diseases (NDs) pose a formidable challenge to healthcare systems worldwide due to their complex pathogenesis, significant morbidity, and mortality. Scope and Approach: This comprehensive review aims to elucidate the central role of the microbiotagut- brain axis (MGBA) in ND pathogenesis. Specifically, it delves into the perturbations within the gut microbiota and its metabolomic landscape, as well as the structural and functional transformations of the gastrointestinal and blood-brain barrier interfaces in ND patients. Additionally, it provides a comprehensive overview of the recent advancements in medicinal and dietary interventions tailored to modulate the MGBA for ND therapy. CONCLUSION: Accumulating evidence underscores the pivotal role of the gut microbiota in ND pathogenesis through the MGBA. Dysbiosis of the gut microbiota and associated metabolites instigate structural modifications and augmented permeability of both the gastrointestinal barrier and the blood-brain barrier (BBB). These alterations facilitate the transit of microbial molecules from the gut to the brain via neural, endocrine, and immune pathways, potentially contributing to the etiology of NDs. Numerous investigational strategies, encompassing prebiotic and probiotic interventions, pharmaceutical trials, and dietary adaptations, are actively explored to harness the microbiota for ND treatment. This work endeavors to enhance our comprehension of the intricate mechanisms underpinning ND pathogenesis, offering valuable insights for the development of innovative therapeutic modalities targeting these debilitating disorders.
650    _2
$a lidé $7 D006801
650    12
$a střevní mikroflóra $x fyziologie $7 D000069196
650    12
$a neurodegenerativní nemoci $x mikrobiologie $x metabolismus $7 D019636
650    12
$a mozek $x metabolismus $7 D001921
650    _2
$a zvířata $7 D000818
650    _2
$a hematoencefalická bariéra $x metabolismus $7 D001812
650    _2
$a dysbióza $x metabolismus $7 D064806
650    12
$a stárnutí $7 D000375
650    12
$a osa mozek-střevo $x fyziologie $7 D000087502
650    _2
$a probiotika $7 D019936
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a You, Li $u College of Physical Education and Health, Chongqing College of International Business and Economics, Chongqing, 401520, China
700    1_
$a Tang, Fang $u College of Humanities and New Media, Yangtze University, Jingzhou, 434025, China
700    1_
$a Duan, Yanhui $u School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China
700    1_
$a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic
700    1_
$a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic $u Biomedical Research Center, University Hospital of Hradec Králové, 500 05, Hradec Králové, Czech Republic
700    1_
$a Wu, Qinghua $u College of Life Science, Yangtze University, Jingzhou, 434025, China $u Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic
700    1_
$a Wei, Wei $u State Key Laboratory for Managing Biotic and Chemical Threats to The Quality and Safety of Agro-Products, Key Laboratory of Traceability for Agricultural Genetically Modified Organisms, Ministry of Agriculture and Rural Affairs, Zhejiang Academy of Agricultural Sciences, Hangzhou, 310021, China
773    0_
$w MED00007890 $t Current neuropharmacology $x 1875-6190 $g Roč. 23, č. 5 (2025), s. 524-546
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39501955 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092905 $b ABA008
999    __
$a ok $b bmc $g 2366938 $s 1253559
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 23 $c 5 $d 524-546 $e - $i 1875-6190 $m Current neuropharmacology $n Curr Neuropharmacol $x MED00007890
GRA    __
$a 32373073 $p National Natural Science Foundation of China
GRA    __
$a 2023KF02 $p Key Laboratory of Traceability for Agricultural Genetically Modified Organisms, Ministry of Agriculture and Rural Affairs
GRA    __
$a UHHK, 00179906 $p MH CZ - DRO
GRA    __
$a 22FWWB003 $p National Social Science Foundation
GRA    __
$a 2216/2023-2024 $p Excellence project PrF UHK, Czech Republic
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Možnosti archivace